Is there a relationship between in vitro drug resistance and level of minimal residual disease as detected by polymerase chain reaction at the end of induction therapy in childhood acute lymphoblastic leukaemia?

被引：9
作者：
de Haas, V [1 ]
Kaspers, GJL
Oosten, L
Bresters, D
Pieters, R
van der Velden, VHJ
van Wering, ER
van den Berg, H
van der Schoot, CE
机构：
[1] Univ Amsterdam, Acad Med Ctr, Emma Kinderziekenhuis, Amsterdam, Netherlands
[2] Netherlands Blood Transfus Serv, Cent Lab, Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Expt & Clin Immunol Lab, NL-1105 AZ Amsterdam, Netherlands
[4] VU Univ Med Ctr, Dept Pediat, Haematol Oncol Sect, Amsterdam, Netherlands
[5] Erasmus Univ, Dept Immunol, NL-3000 DR Rotterdam, Netherlands
[6] Erasmus Univ, Sophia Childrens Hosp, Rotterdam, Netherlands
[7] Dutch Childhood Leukaemia Study Grp, The Hague, Netherlands
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2002年 / 118卷 / 04期
关键词：
drug resistance; MRD; MTT assay; RQ-PCR;
D O I：
10.1046/j.1365-2141.2002.36211.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1190 / 1191
页数：2
相关论文
共 7 条
[1]   Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy [J].
de Haas, V ;
Verhagen, OJHM ;
von dem Borne, AEGK ;
Kroes, W ;
van den Berg, H ;
van der Schoot, CE .
LEUKEMIA, 2001, 15 (01) :134-140
[2]   In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia [J].
Kaspers, GJL ;
Veerman, AJP ;
Pieters, R ;
VanZantwijk, CH ;
Smets, LA ;
VanWering, ER ;
DenBerg, AV .
BLOOD, 1997, 90 (07) :2723-2729
[3]   Prednisolone resistance in childhood acute lymphoblastic leukemia: Vitro-vivo correlations and cross-resistance to other drugs [J].
Kaspers, GJL ;
Pieters, R ;
Van Zantwijk, CH ;
Van Wering, ER ;
Van der Does-Van den Berg, A ;
Veerman, AJP .
BLOOD, 1998, 92 (01) :259-266
[4]   Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance [J].
Schmiegelow, K ;
Nyvold, C ;
Seyfarth, J ;
Pieters, R ;
Rottier, MMA ;
Knabe, N ;
Ryder, LP ;
Madsen, HO ;
Svejgaard, A ;
Kaspers, GJL .
LEUKEMIA, 2001, 15 (07) :1066-1071
[5]   Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995 [J].
Schrappe, M ;
Reiter, A ;
Zimmermann, M ;
Harbott, J ;
Ludwig, WD ;
Henze, G ;
Gadner, H ;
Odenwald, E ;
Riehm, H .
LEUKEMIA, 2000, 14 (12) :2205-2222
[6]   Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood [J].
van Dongen, JJM ;
Seriu, T ;
Panzer-Grümayer, ER ;
Biondi, A ;
Pongers-Willemse, MJ ;
Corral, L ;
Stolz, F ;
Schrappe, M ;
Masera, G ;
Kamps, WA ;
Gadner, H ;
van Wering, ER ;
Ludwig, WD ;
Basso, G ;
de Bruijn, MAC ;
Cazzaniga, G ;
Hettinger, A ;
van der Does-van den Berg, A ;
Hop, WCJ ;
Riehm, H ;
Bartram, CR .
LANCET, 1998, 352 (9142) :1731-1738
[7]   Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia [J].
Verhagen, OJHM ;
Willemse, MJ ;
Breunis, WB ;
Wijkhuijs, AJM ;
Jacobs, DCH ;
Joosten, SA ;
van Wering, ER ;
van Dongen, JJM ;
van der Schoot, CE .
LEUKEMIA, 2000, 14 (08) :1426-1435
1